In fact, a study of various glioma cell lines revealed no correlation between TRAIL sensitivity and the expression of TRAIL receptors DR4/5, but noted that TRAIL-resistant GBM lines had a high level of basal NF-κB activity35. The gene discussed is TNFSF10; the disease is glioblastoma.